Philip Jones Selected Research

C-Reactive Protein

12/2017	Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries.
11/2017	High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip Jones Research Topics

Disease

38	Neoplasms (Cancer) 04/2024 - 12/2006
7	Heart Failure 04/2024 - 12/2008
6	Myocardial Infarction 12/2019 - 07/2011
5	Hemorrhage 01/2021 - 02/2017
5	Infections 01/2011 - 03/2004
4	Bites and Stings (Sting) 03/2024 - 10/2019
3	Triple Negative Breast Neoplasms 04/2024 - 11/2021
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2018
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 10/2021
3	Cardiomyopathies (Cardiomyopathy) 12/2022 - 10/2005
3	Adenocarcinoma 01/2021 - 10/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 09/2008
2	Pain (Aches) 05/2023 - 04/2021
2	Dyspnea (Shortness of Breath) 01/2022 - 01/2018
2	Cognitive Dysfunction 10/2021 - 02/2006
2	Stroke (Strokes) 12/2019 - 01/2018
2	Leukemia 02/2016 - 09/2015
2	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 04/2015
1	Overactive Urinary Bladder (Overactive Bladder) 01/2023
1	Urinary Incontinence 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Consciousness Disorders 12/2022
1	Seizures (Absence Seizure) 12/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 09/2022
1	Ketosis 01/2022
1	Rothmund-Thomson Syndrome (Syndrome, Rothmund-Thomson) 12/2021
1	Osteosarcoma (Osteogenic Sarcoma) 12/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Chemotherapy-Related Cognitive Impairment 10/2021
1	Hyperalgesia 10/2021
1	Pulmonary Embolism 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 03/2024 - 09/2007
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2023 - 08/2009
6	Histones (Histone)IBA 01/2023 - 09/2007
6	Histone Deacetylases (Histone Deacetylase)IBA 06/2009 - 12/2006
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2007
4	Histone Deacetylase InhibitorsIBA 10/2008 - 12/2006
3	InterferonsIBA 03/2024 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2005
3	IACS-010759IBA 01/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 11/2021 - 05/2015
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2016 - 11/2009
2	SodiumIBA 04/2024 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2022
2	Complementary DNA (cDNA)IBA 03/2024 - 09/2015
2	Protein Isoforms (Isoforms)IBA 03/2024 - 03/2015
2	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2022
2	Natriuretic PeptidesIBA 01/2023 - 01/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 10/2005
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2022 - 03/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 02/2016
2	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 12/2012
2	C-Reactive ProteinIBA 12/2017 - 11/2017
2	Warfarin (Coumadin)FDA LinkGeneric 02/2017 - 12/2012
2	Adenosine Triphosphatases (ATPase)IBA 09/2015 - 03/2015
2	niraparibIBA 04/2015 - 11/2009
2	PyrazinesIBA 08/2011 - 08/2011
2	8a- methyl- 1,3- dioxo- 2- (2- phenylcyclopropyl)- N- (1- phenyl- 1H- pyrazol- 5- yl)hexahydroimidazo(1,5- a)pyrazine- 7(1H)- carboxamideIBA 08/2011 - 08/2011
1	CREB-Binding ProteinIBA 04/2024
1	SymportersIBA 04/2024
1	Interferon Type IIBA 03/2024
1	Opioid Analgesics (Opioids)IBA 05/2023
1	empagliflozinIBA 01/2023
1	Muscarinic AntagonistsIBA 01/2023
1	fesoterodine FDA Link 01/2023
1	Retinaldehyde (Retinal)IBA 12/2022
1	binimetinibIBA 09/2022
1	palbociclibIBA 09/2022
1	acylcarnitineIBA 01/2022
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022
1	dapagliflozinIBA 01/2022
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 12/2021
1	ClaudinsIBA 12/2021
1	Mitogen-Activated Protein KinasesIBA 10/2021
1	compound 30IBA 10/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021
1	PlatinumIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Glutamine (L-Glutamine)FDA Link 11/2020
1	osimertinibIBA 11/2020
1	Tyrosine Kinase InhibitorsIBA 11/2020

Therapy/Procedure

25	Therapeutics 02/2024 - 12/2006
5	Length of Stay 05/2023 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2023 - 07/2011
4	Percutaneous Coronary Intervention 12/2019 - 02/2017
3	Immunotherapy 01/2021 - 01/2011
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2022 - 12/2019
2	Catheters 01/2021 - 11/2014
2	Blood Transfusion (Blood Transfusions) 12/2019 - 01/2018
2	Drug-Eluting Stents 01/2019 - 02/2017
2	Renal Dialysis (Hemodialysis) 01/2018 - 06/2005
1	Liver Transplantation 12/2022
1	Neoadjuvant Therapy 11/2021
1	Patient Readmission 01/2021